Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy

ISSN： 1756-8927

Source： Future Medicinal Chemistry, Vol.5, Iss.12, 2013-08, pp. : 1451-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia signaling to genes: Significance in Alzheimer’s disease

By Bazan Nicolas Palacios-Pelaez Ricardo Lukiw Walter

Molecular Neurobiology, Vol. 26, Iss. 2-3, 2002-10 ,pp. : 283-298

Humana Press, Inc

Access to resources Recommend Favorite

Immunological approaches as therapy for Alzheimer’s disease

By Solomon Beka

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 907-917

Informa Healthcare

Access to resources Recommend Favorite

Autophagy Modulation for Alzheimer’s Disease Therapy

By Zhu Xi-Chen Yu Jin-Tai Jiang Teng Tan Lan

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 702-714

Humana Press, Inc

Access to resources Recommend Favorite

Oxidative imbalance in alzheimer’s disease

By Zhu Xiongwei Lee Hyoung-gon Casadesus Gemma Avila Jesus Drew Kelly Perry George Smith Mark

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 205-217

Humana Press, Inc

Access to resources Recommend Favorite

Molecular basis of Alzheimer’s disease

By Grigorenko A. Rogaev E.

Molecular Biology, Vol. 41, Iss. 2, 2007-04 ,pp. : 294-307

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite